Meeder Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.9K	Buy	17 +10	+143%	+$4.78K	﹤0.01%	720
2025 Q4	$4.08K	Hold	7	–	–	﹤0.01%	820
2025 Q3	$3.21K	Buy	+7	New	+$2.61K	﹤0.01%	737
2025 Q2	–	Sell	-5	Closed	-$1.66K	–	949
2025 Q1	$1.66K	Sell	5 -2	-29%	-$657	﹤0.01%	877
2024 Q4	$2.16K	Buy	+7	New	+$1.97K	﹤0.01%	886
2024 Q2	–	Sell	-10	Closed	-$2.67K	–	938
2024 Q1	$2.67K	Buy	+10	New	+$2.36K	﹤0.01%	703
2021 Q3	–	Sell	-3,364	Closed	-$328K	–	2576
2021 Q2	$328K	Buy	+3,364	New	+$398K	0.02%	621
2019 Q1	–	Sell	-557	Closed	-$63K	–	1790
2018 Q4	$63K	Sell	557 -5	-0.9%	-$774	0.01%	752
2018 Q3	$120K	Buy	562 +126	+29%	+$31.6K	0.01%	607
2018 Q2	$122K	Buy	436 +326	+296%	+$57.2K	0.01%	591
2018 Q1	$13K	Buy	110 +3	+3%	+$370	﹤0.01%	1000
2017 Q4	$10K	Buy	107 +90	+529%	+$5.14K	﹤0.01%	1126
2017 Q3	$1K	Buy	+17	New	+$318	﹤0.01%	1553